Lucene search

K
cvelist3DSCVELIST:CVE-2023-6078
HistoryFeb 01, 2024 - 1:33 p.m.

CVE-2023-6078 OS Command Injection vulnerability affecting BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023

2024-02-0113:33:48
CWE-78
3DS
www.cve.org
cve-2023
os command injection
biovia materials studio
release biovia 2021
release biovia 2023
perl script

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

10 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

41.4%

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

CNA Affected

[
  {
    "vendor": "Dassault Systèmes",
    "product": "BIOVIA Materials Studio products",
    "versions": [
      {
        "status": "affected",
        "version": "BIOVIA 2021 Golden"
      },
      {
        "status": "affected",
        "version": "BIOVIA 2022 Golden"
      },
      {
        "status": "affected",
        "version": "BIOVIA 2023 Golden"
      }
    ],
    "defaultStatus": "unaffected"
  }
]

8.8 High

CVSS3

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality Impact

HIGH

Integrity Impact

HIGH

Availability Impact

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

10 High

AI Score

Confidence

High

0.001 Low

EPSS

Percentile

41.4%

Related for CVELIST:CVE-2023-6078